151 related articles for article (PubMed ID: 17269706)
1. Tumour metabolomics in animal models of human cancer.
Griffin JL; Kauppinen RA
J Proteome Res; 2007 Feb; 6(2):498-505. PubMed ID: 17269706
[TBL] [Abstract][Full Text] [Related]
2. A metabolomics perspective of human brain tumours.
Griffin JL; Kauppinen RA
FEBS J; 2007 Mar; 274(5):1132-9. PubMed ID: 17298437
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiles of cancer cells.
Griffin JL; Shockcor JP
Nat Rev Cancer; 2004 Jul; 4(7):551-61. PubMed ID: 15229480
[No Abstract] [Full Text] [Related]
4. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.
Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Kvistad KA; Lundgren S; Gribbestad IS
BMC Cancer; 2007 Jul; 7():141. PubMed ID: 17662122
[TBL] [Abstract][Full Text] [Related]
5. The betaII isotype of tubulin is present in the cell nuclei of a variety of cancers.
Yeh IT; Ludueña RF
Cell Motil Cytoskeleton; 2004 Feb; 57(2):96-106. PubMed ID: 14691949
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
8. Tumor models and specific contrast agents for small animal imaging in oncology.
Ni Y; Wang H; Chen F; Li J; DeKeyzer F; Feng Y; Yu J; Bosmans H; Marchal G
Methods; 2009 Jun; 48(2):125-38. PubMed ID: 19328231
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy of neoplasms.
Maris JM; Chance B
Magn Reson Annu; 1986; ():213-35. PubMed ID: 3079339
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
11. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies.
Tzika AA; Astrakas L; Cao H; Mintzopoulos D; Andronesi OC; Mindrinos M; Zhang J; Rahme LG; Blekas KD; Likas AC; Galatsanos NP; Carroll RS; Black PM
Int J Mol Med; 2007 Aug; 20(2):199-208. PubMed ID: 17611638
[TBL] [Abstract][Full Text] [Related]
12. Raman spectroscopy can differentiate malignant tumors from normal breast tissue and detect early neoplastic changes in a mouse model.
Kast RE; Serhatkulu GK; Cao A; Pandya AK; Dai H; Thakur JS; Naik VM; Naik R; Klein MD; Auner GW; Rabah R
Biopolymers; 2008 Mar; 89(3):235-41. PubMed ID: 18041066
[TBL] [Abstract][Full Text] [Related]
13. Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy.
Ellis DI; Goodacre R
Analyst; 2006 Aug; 131(8):875-85. PubMed ID: 17028718
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications.
Soares DP; Law M
Clin Radiol; 2009 Jan; 64(1):12-21. PubMed ID: 19070693
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids for cancer treatment: progress and promise.
Sarfaraz S; Adhami VM; Syed DN; Afaq F; Mukhtar H
Cancer Res; 2008 Jan; 68(2):339-42. PubMed ID: 18199524
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
Goda AE; Yoshida T; Horinaka M; Yasuda T; Shiraishi T; Wakada M; Sakai T
Oncogene; 2008 May; 27(24):3435-45. PubMed ID: 18193086
[TBL] [Abstract][Full Text] [Related]
17. Characterization of de novo synthesized proteins released from human colorectal tumour explants.
Shi HJ; Stubbs R; Hood K
Electrophoresis; 2009 Jul; 30(14):2442-53. PubMed ID: 19639566
[TBL] [Abstract][Full Text] [Related]
18. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
Jordan KW; Cheng LL
Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
[TBL] [Abstract][Full Text] [Related]
19. [Neurospecific proteins: potentials and prospects for their use in morphological research on tumors].
Zhmareva EN; Brodskaia IA; Berezin VA; Shevchenko GM
Arkh Patol; 1987; 49(4):87-91. PubMed ID: 3300612
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
Morvan D; Demidem A
Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
